Production (Stage)
Opus Genetics, Inc.
IRD
$1.04
$0.044.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 1.58% | 11.25% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.58% | 11.25% | |||
| Cost of Revenue | 1.39% | -11.07% | |||
| Gross Profit | -1.15% | 28.76% | |||
| SG&A Expenses | -11.79% | 150.43% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.22% | 20.67% | |||
| Operating Income | 1.00% | -25.22% | |||
| Income Before Tax | 76.68% | -366.85% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 76.68% | -366.85% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 76.68% | -366.85% | |||
| EBIT | 1.00% | -25.22% | |||
| EBITDA | 1.10% | -25.21% | |||
| EPS Basic | 79.11% | -301.98% | |||
| Normalized Basic EPS | -2.86% | 18.34% | |||
| EPS Diluted | 79.11% | -299.07% | |||
| Normalized Diluted EPS | -2.86% | 18.34% | |||
| Average Basic Shares Outstanding | 11.61% | 16.12% | |||
| Average Diluted Shares Outstanding | 11.61% | 16.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||